Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug ...

In a Jan. 10 precedential ruling by the United States Court of Appeals for the Federal Circuit, the validity of the U.S. patent covering ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a legal complaint from Novartis seeking to block its launch. In August, a Delaware ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...

Doses were titrated over 6 months (daily maximums, 160 mg and 10 mg, respectively), and agents from other drug classes were ... treatment previously. Valsartan's manufacturer sponsored the trial.

The recall list is long, covering valsartan prescriptions in a number of different dosages and amounts. A number of different ...

Indian Biotechnology firm Biocon has received approval of its ANDA for Sacubitril/Valsartan Tablets from the US Food and Drug ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district court’s ...

Discover all the brand names or Trade names of generic drug called Valsartan. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

In our Case of the Week, the Federal Circuit revived Novartis’s US Patent No. 8,101,659 by reversing the district court’s decision which found the patent invalid for lack of written description. The ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...